Vimarsana
Biggest News Aggregation in the World

Biosimilar Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biosimilar Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biosimilar Development Today - Breaking & Trending Today

Russell D Cohen, MD: Understanding the Role of Biosimilars in Healthcare - Vimarsana News

Russell D Cohen, MD: Understanding the Role of Biosimilars in Healthcare

Russell D Cohen, MD, explains how biosimilars represent an opportunity to expand access and reduce the financial burden of high-cost biologics.

A Look at FDA's Proposed Changes to Labeling for Biosimilars and Interchangeable Biosimilars | Foley & Lardner LLP - Vimarsana News

A Look at FDA's Proposed Changes to Labeling for Biosimilars and Interchangeable Biosimilars | Foley & Lardner LLP

The labeling of biosimilar products as “interchangeable” may be important in order to gain acceptance and use in the medical community. This article provides important information...

Sandoz Inaugurates New Antibiotic Production Plant, Biosimilar Development Center - Vimarsana News

Sandoz Inaugurates New Antibiotic Production Plant, Biosimilar Development Center

Sandoz has launched a new antibiotic production plant in Austria along with a biosimilar development center in Germany. The units are in line with the firm’s aim to strengthen sustainable development and supply of critical medicines in Europe and other regions of the world.

New FDA Guidance Removes Interchangeability Statement from Product Labels | Venable LLP - Vimarsana News

New FDA Guidance Removes Interchangeability Statement from Product Labels | Venable LLP

On September 18, 2023, the FDA issued a new draft guidance “Labeling for Biosimilar and Interchangeable Biosimilar Products,” updating the previous labeling guidance “Labeling for...

Are You Not Interchanged? FDA's Recent Biosimilar Labeling Guidance Chips Away at Interchangeable Product Advantages. | Foley Hoag LLP - Vimarsana News

Are You Not Interchanged? FDA's Recent Biosimilar Labeling Guidance Chips Away at Interchangeable Product Advantages. | Foley Hoag LLP

Interchangeable biosimilar products would not be allowed to disclose or explain their interchangeability designations in their products’ labels under FDA’s new draft guidance. ...